Events Events | Centre of Excellence for Long-acting Therapeutics- Centre of Excellence for Long-acting Therapeutics

Conference on Retroviruses and Opportunistic Infections (CROI)

9-12 March 2025, San Francisco USA

On Sunday 9 - Wedensday 12 March, CROI will host it's annual conference. The aim is to provide a forum for scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases.

We're pleased to say that CELT researchers, Dr Usman Arshad and Dr Henry Pertinez, will be presenting a poster showcasing some exciting preclinical pharmacokinetic research from the LONGEVITY project. As well as CELT staff, LONGEVITY partners University of Nebraska Medical Center will also be presenting LONGEVITY findings at CROI 2025.

Find out more about the conference and registration here.

WEBINAR: CELT's Community of Practice; Long-acting therapeutics for maternal and paediatric health

19 March 2025, online

Topic: Dynamic paediatric and maternal physiology in long-acting therapeutics development

Speaker 1 - Prof. Robert Bies: Considerations for pregnancy
Rob Bies is Professor of Pharmaceutical Sciences at the School of Pharmacy and Pharmaceutical Sciences at University of Buffalo and the protocol Pharmacologist for IMPAACT 2040.
Speaker 2 - TBC: Considerations for paediatrics

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this community of practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
Synthesise evidence-based perspectives on best practices for long-acting therapeutics
Disseminate outputs from the community of practice for uptake by the wider community.

There are 9 meetings for the community of practice in 2025 (2 full community of practice meetings online (one has already occurred), 1 in person workshop and 6 shorter webinars). The webinar will be held 12-1.30pm (GMT) on Wednesday 19 March, 2025.

To join the Community of Practice and this webinar, please fill out this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. Members are welcome to join the community of practice at any point.

International workshop on long-acting anti-infectives 2025. Abstract submission deadline Friday 28 February 2025. Abstract categories: LA formulations for treatment of infections; Prevention of key infections with LA formulations; regulatory, end user and implementation issues; LA anti-infectives for key populations; future directions and novel platforms for LAAI therapies; monoclonal antibodies.

First International Workshop on Long-acting Anti-infectives (LAAI)

21-22 May 2025, New Orleans USA

CELT endorse this is the first meeting of this workshop, hosted by Academic Medical Education's Virology Education. The LAAI is a platform to advance development, implementation, and scale-up of long-acting anti-infective therapies. The first edition of the workshop will explore the transformative potential of long-acting drug delivery in infectious disease management, with a focus on recent breakthroughs in HIV prevention and treatment.

Find more information about the LAAI workshop, including how to register and submit an abstract.

#LAAIWS

A grand building at Queens University Belfast is above the text

British Society for Nanomedicine 2025 Annual Meeting

2-3 September 2025, Queens University Belfast Ireland

With four incredible keynote speakers, this two day event includes presentations (with an emphasis on early career researchers, industry and academic taskforce meetings, workshops, and discussion groups.

Find out more including how to register and submit an abstract via the BSNM Annual Meeting event page.

Abstract submission deadline: 30 June 2025
Registration deadline: 11 July 2025

A flyer stating

26th International workshop on clinical pharmacology of HIV, hepatitis and other antiviral drugs 2025

3-4 September 2025, Amsterdam The Netherlands

CELT are an official endorser to the 26th Antiviral Workshop 2025, set to take place on 3-4 September in Amsterdam, the Netherlands.

This prestigious workshop brings together leading experts, researchers, and professionals from the field of clinical pharmacology to exchange knowledge, share insights, and discuss the latest therapeutic advancements for HIV, hepatitis, and other antiviral drugs.

Find out more information, including how to register and submit an abstract on the Antiviral Workshop 2025 event page.

Abstract Submission

Deadline: Friday, 30 May at 23:59 CEST

Abstract Categories:

Cellular and Tissue Pharmacokinetics
Drug-Drug Interactions
Novel Drugs and Formulations
Pharmacogenetics
Pharmacogenetics During Pregnancy and Other Key Populations
PK/PD of Drug Efficacy and Toxicity (Including TDM)

You can submit abstracts through the Antiviral Workshop 2025 abstract submission portal.

Previous events

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks here.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch CELT co-Director Prof. Andrew Owen's presentation here.

Find all the recordings from the workshop here.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks here